COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper.

Addiction medicine Coronavirus Coronavirus Disease 2019 (COVID-19) Harm reduction Methadone Opioid substitution therapy Pandemic Policy Public health Substance use disorder

Journal

Basic and clinical neuroscience
ISSN: 2008-126X
Titre abrégé: Basic Clin Neurosci
Pays: Iran
ID NLM: 101575211

Informations de publication

Date de publication:
Historique:
received: 07 04 2020
revised: 08 04 2020
accepted: 09 04 2020
entrez: 29 8 2020
pubmed: 29 8 2020
medline: 29 8 2020
Statut: ppublish

Résumé

Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).

Identifiants

pubmed: 32855772
doi: 10.32598/bcn.11.covid19.1
pii: BCN-11-133
pmc: PMC7368103
doi:

Types de publication

Journal Article

Langues

eng

Pagination

133-150

Informations de copyright

Copyright© 2020 Iranian Neuroscience Society.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

BMC Infect Dis. 2017 Jan 3;17(1):4
pubmed: 28049440
Methodist Debakey Cardiovasc J. 2015 Jul-Sep;11(3):189-91
pubmed: 26634029
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Clin Infect Dis. 2009 Jun 15;48(12):1787-9
pubmed: 19432553
Drug Alcohol Depend. 2017 Nov 1;180:204-207
pubmed: 28918239
Front Immunol. 2019 Oct 15;10:2435
pubmed: 31749792
Clin Infect Dis. 1995 Nov;21(5):1253-64
pubmed: 8589151
Addiction. 2006 Feb;101(2):267-74
pubmed: 16445555
Ann Thorac Med. 2011 Apr;6(2):91-5
pubmed: 21572699
Health Serv Res. 2003 Dec;38(6 Pt 2):1735-59
pubmed: 14727795
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
J Epidemiol Glob Health. 2017 Mar;7(1):29-36
pubmed: 27302882
Ann Emerg Med. 1984 Dec;13(12):1145-7
pubmed: 6507974
J Pain Symptom Manage. 2000 Oct;20(4):237-45
pubmed: 11027904
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Psychiatr Serv. 2008 Jan;59(1):91-5
pubmed: 18182545
J Anal Toxicol. 2002 Jan-Feb;26(1):58
pubmed: 11888019
Clin Chem. 2006 May;52(5):896-7
pubmed: 16638958
Annu Rev Clin Psychol. 2007;3:257-84
pubmed: 17716056
Transl Perioper Pain Med. 2016;1(1):5-13
pubmed: 26985446
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
J Pain. 2003 Jun;4(5):289-90
pubmed: 14622699
Drug Alcohol Depend. 2007 May 11;88(2-3):188-96
pubmed: 17118578
Bioanalysis. 2009 Aug;1(5):937-52
pubmed: 21083064
Eur J Public Health. 2007 Dec;17(6):612-7
pubmed: 17412715
BMJ. 2010 Oct 26;341:c5475
pubmed: 20978062
Biosci Trends. 2020 Mar 16;14(1):72-73
pubmed: 32074550
Addict Health. 2012 Summer-Autumn;4(3-4):111-6
pubmed: 24494144
Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):747-53
pubmed: 15918160
Pain Physician. 2011 Mar-Apr;14(2):145-61
pubmed: 21412369
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Ann Intern Med. 1970 Jul;73(1):81-5
pubmed: 5433281
Iran J Public Health. 2016 Jan;45(1):109-11
pubmed: 27057532
Brain Res. 2009 Oct 13;1293:61-75
pubmed: 19332030
Psychiatr Clin North Am. 2013 Sep;36(3):385-402
pubmed: 23954054
W V Med J. 2009 Jan-Feb;105(1):18-9
pubmed: 19146042
Pain. 2001 Aug;93(2):155-63
pubmed: 11427327
Acta Anaesthesiol Scand. 2007 Feb;51(2):262-4
pubmed: 17261153
Front Psychiatry. 2013 Aug 01;4:72
pubmed: 23914176
Eur J Clin Microbiol Infect Dis. 2007 May;26(5):367-9
pubmed: 17440756
Am J Kidney Dis. 1986 Dec;8(6):404-9
pubmed: 3812469
Neuron. 2008 Jul 10;59(1):11-34
pubmed: 18614026
Trials. 2018 Dec 10;19(1):675
pubmed: 30526648
J Korean Med Sci. 2020 Feb 17;35(6):e79
pubmed: 32056407
Lancet. 2020 Feb 22;395(10224):e37-e38
pubmed: 32043982
Iran Red Crescent Med J. 2015 Jun 23;17(6):e22612
pubmed: 26380798
Trends Mol Med. 2018 Feb;24(2):173-186
pubmed: 29396148
Am Surg. 2010 Apr;76(4):397-9
pubmed: 20420250
J Subst Abuse Treat. 2017 Jan;72:117-125
pubmed: 27394070
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
N Engl J Med. 2019 Jan 3;380(1):71-79
pubmed: 30601750
Environ Health. 2013 Dec 20;12:115
pubmed: 24359448
Eur Arch Psychiatry Clin Neurosci. 2012 Feb;262(1):47-57
pubmed: 21773812
Nat Rev Drug Discov. 2020 Mar;19(3):149-150
pubmed: 32127666
Int J Nurs Sci. 2016 Dec 11;4(1):63-67
pubmed: 31406720
Saudi J Biol Sci. 2019 Jul;26(5):938-941
pubmed: 31303822
Lancet. 2009 Oct 10;374(9697):1284-93
pubmed: 19819393
Nutrition. 2019 Apr;60:161-169
pubmed: 30599460
J Clin Epidemiol. 2007 Aug;60(8):795-802
pubmed: 17606175
Int J STD AIDS. 2009 May;20(5):320-3
pubmed: 19386968
JAMA. 2020 Feb 24;:
pubmed: 32091533
Emerg Infect Dis. 2016 Jan;22(1):49-55
pubmed: 26692185
BMJ. 2020 Feb 19;368:m627
pubmed: 32075791
Emerg Infect Dis. 2006 Dec;12(12):1924-32
pubmed: 17326946
Am J Kidney Dis. 2001 Sep;38(3):523-8
pubmed: 11532684
J Neuroimmune Pharmacol. 2011 Dec;6(4):442-65
pubmed: 21789507
Aust N Z J Public Health. 2020 Apr;44(2):163-168
pubmed: 32101355
World Psychiatry. 2017 Jun;16(2):213-214
pubmed: 28498572
J Subst Abuse Treat. 2011 Jun;40(4):323-35
pubmed: 21257281
J Consult Clin Psychol. 2003 Apr;71(2):320-9
pubmed: 12699026
JAMA. 2020 Feb 7;:
pubmed: 32031570
Curr Pain Headache Rep. 2006 Feb;10(1):67-70
pubmed: 16499832
Can J Anaesth. 2019 Feb;66(2):201-217
pubmed: 30484167
Clin Cardiol. 1983 Apr;6(4):189-91
pubmed: 6839571
Addict Health. 2014 Summer-Autumn;6(3-4):146-54
pubmed: 25984282
PLoS Med. 2018 Dec 26;15(12):e1002715
pubmed: 30586362
N Engl J Med. 2005 Nov 3;353(18):1945-54
pubmed: 16267325
Drug Alcohol Depend. 2017 Sep 1;178:318-339
pubmed: 28688295
Addiction. 2014 Sep;109(9):1426-36
pubmed: 24750232
Prev Med. 2006 Jul;43(1):60-70
pubmed: 16684559
J Subst Abuse Treat. 1995 Mar-Apr;12(2):117-27
pubmed: 7623389
Br J Addict Alcohol Other Drugs. 1978 Jun;73(2):178-80
pubmed: 276373
Am J Med Sci. 2013 Feb;345(2):160-2
pubmed: 23103438
N Engl J Med. 1993 Dec 23;329(26):1927-34
pubmed: 8247056
Addiction. 2011 Jun;106(6):1114-25
pubmed: 21320230
J Addict Med. 2020 Feb 06;:
pubmed: 32032212
J Toxicol Clin Toxicol. 1987;25(1-2):135-48
pubmed: 3586084
South Med J. 1977 Jan;70(1):108-9
pubmed: 841359
Drug Alcohol Depend. 2016 Feb 1;159:35-41
pubmed: 26703856
Radiology. 2020 Aug;296(2):E15-E25
pubmed: 32083985
Int Immunopharmacol. 2010 Oct;10(10):1229-34
pubmed: 20637837
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Curr Drug Abuse Rev. 2008 Jan;1(1):56-67
pubmed: 19630706
Eur J Intern Med. 2017 Sep;43:1-5
pubmed: 28647343
BMJ Open. 2017 Mar 30;7(3):e014643
pubmed: 28363929
Pharmacol Res. 2004 Dec;50(6):551-9
pubmed: 15501692
Am J Med. 1987 Sep;83(3):601
pubmed: 3661597
Cardiovasc Toxicol. 2017 Jan;17(1):13-24
pubmed: 27663745
Eur Neuropsychopharmacol. 2003 Dec;13(6):435-41
pubmed: 14636959
Addiction. 2020 Jul;115(7):1395-1403
pubmed: 31737965
Drug Alcohol Depend. 2009 Nov 1;105(1-2):9-15
pubmed: 19608355
Int J Chron Obstruct Pulmon Dis. 2011;6:89-95
pubmed: 21407821
Anesthesiology. 1998 May;88(5):1154-61
pubmed: 9605673
Lancet Infect Dis. 2017 May;17(5):e128-e143
pubmed: 28291721
Pain. 2006 Feb;120(3):267-75
pubmed: 16427197
Am J Addict. 2010 Nov-Dec;19(6):557-68
pubmed: 20958853
Subst Abuse Treat Prev Policy. 2009 May 08;4:10
pubmed: 19426474
JAMA. 2020 Feb 21;:
pubmed: 32083643
Cardiovasc Drugs Ther. 1994 Feb;8(1):89-94
pubmed: 8086332
Int J Environ Res Public Health. 2016 Nov 10;13(11):
pubmed: 27834915
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
J Anal Toxicol. 2014 Sep;38(7):387-96
pubmed: 24986836
CMAJ. 2004 Apr 13;170(8):1251-2
pubmed: 15078847
J Pain Palliat Care Pharmacother. 2007;21(2):5-16
pubmed: 17844723
Br Med J. 1967 Sep 2;3(5565):603-5
pubmed: 20791354
Lancet. 2020 Feb 22;395(10224):542-545
pubmed: 32061313
Int J Infect Dis. 2017 May;58:37-42
pubmed: 28223175
Lancet Infect Dis. 2017 May;17(5):e144-e158
pubmed: 28291722
Am J Psychiatry. 1966 Jan;122(7):742-4
pubmed: 5900467
Int J Tuberc Lung Dis. 2003 Sep;7(9):860-5
pubmed: 12971670
J Pain. 2015 Sep;16(9):887-94
pubmed: 26101814
Brain Behav Immun. 2008 May;22(4):606-13
pubmed: 18294814
Am J Med. 1980 Jan;68(1):47-53
pubmed: 7350805
Int J Prev Med. 2014 Aug;5(8):976-83
pubmed: 25489445
Drug Alcohol Rev. 2008 May;27(3):309-17
pubmed: 18368613
Pediatrics. 2005 Jul;116(1):e113-9
pubmed: 15995011
Ann Intern Med. 2002 Sep 17;137(6):501-4
pubmed: 12230351
Nephrol Dial Transplant. 2003 Nov;18(11):2308-13
pubmed: 14551358
Neuropharmacology. 2014 Jan;76 Pt B:370-82
pubmed: 23747571
Am J Epidemiol. 1999 Dec 15;150(12):1275-81
pubmed: 10604769
Addiction. 2015 Jun;110(6):891-8
pubmed: 25490943

Auteurs

Ali Farhoudian (A)

Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran.
Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Alexander Baldacchino (A)

Division of Population and Behavioral Sciences, St Andrews University Medical School, University of St Andrews, UK.

Nicolas Clark (N)

North Richmond Community Health, Victoria, Melbourne, Australia.
Royal Melbourne Hospital, Victoria, Melbourne, Australia.

Gilberto Gerra (G)

Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime, Vienna, Austria.

Hamed Ekhtiari (H)

Laureate Institute for Brain Research, Tulsa, Oklahoma, USA.

Geert Dom (G)

Collaborative Antwerp Psychiatric Research Institute, University of Antwerp, Antwerp, Belgium.

Azarakhsh Mokri (A)

Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran.

Mandana Sadeghi (M)

Aftab Mehrvarzi Substance Abuse Treatment Center, Tehran, Iran.

Pardis Nematollahi (P)

Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Maryanne Demasi (M)

North Richmond Community Health, Victoria, Melbourne, Australia.

Christian G Schütz (CG)

Department of Psychiatry, University of British Columbia, Vancouver BC, Canada.

Seyed Mohammadreza Hash-Emian (SM)

Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Payam Tabarsi (P)

Clinical Tuberculosis and Epidemiology Research Center, National Research Institute for Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Susanna Galea-Singer (S)

Institute for Innovation and Improvement, IWaitematâ DHB, Centre for Addictions Research, University of Auckland, Auckland, New Zealand.

Giuseppe Carrà (G)

Department of Medicine and Surgery, Section of Psychiatry, University of Milan Bicocca, Milan, Italy.

Thomas Clausen (T)

Norwegian Centre for Addiction Research (SERAF); University of Oslo, Oslo, Norway.

Christos Kouimtsidis (C)

General Secretariat of Prime Minister, Ministry of Health, Athens, Greece.

Serenella Tolomeo (S)

Department of Psychology, National University of Singapore (NUS), Singapore.

Seyed Ramin Radfar (SR)

Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Integrated Substance Abuse Programs, University of California, Los Angeles, California, USA.

Emran Mohammad Razaghi (EM)

Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran.

Classifications MeSH